toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
  Record Links
Author (up) Raad, I.; Chaftari, A.-M.; Zakhour, R.; Jordan, M.; Al Hamal, Z.; Jiang, Y.; Yousif, A.; Garoge, K.; Mulanovich, V.; Viola, G.M.; Kanj, S.; Pravinkumar, E.; Rosenblatt, J.; Hachem, R. url  doi
  Title Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol Type Journal Article
  Year 2016 Publication Antimicrobial Agents and Chemotherapy Abbreviated Journal Antimicrob Agents Chemother  
  Volume 60 Issue 6 Pages 3426-3432  
  Keywords Adult; Aged; Anti-Bacterial Agents/*therapeutic use; Bacteremia/*drug therapy/prevention & control; Biofilms/drug effects; Catheter-Related Infections/*drug therapy/prevention & control; Catheterization, Central Venous/*adverse effects; Central Venous Catheters/adverse effects/*microbiology; Edetic Acid/*therapeutic use; Ethanol/*therapeutic use; Female; Humans; Male; Middle Aged; Minocycline/*therapeutic use; Neoplasms/therapy; Pilot Projects; Prospective Studies; Treatment Outcome; Young Adult  
  Abstract In cancer patients with long-term central venous catheters (CVC), removal and reinsertion of a new CVC at a different site might be difficult because of the unavailability of accessible vascular sites. In vitro and animal studies showed that a minocycline-EDTA-ethanol (M-EDTA-EtOH) lock solution may eradicate microbial organisms in biofilms, hence enabling the treatment of central line-associated bloodstream infections (CLABSI) while retaining the catheter in situ Between April 2013 and July 2014, we enrolled 30 patients with CLABSI in a prospective study and compared them to a historical group of 60 patients with CLABSI who had their CVC removed and a new CVC inserted. Each catheter lumen was locked with an M-EDTA-EtOH solution for 2 h administered once daily, for a total of 7 doses. Patients who received locks had clinical characteristics that were comparable to those of the control group. The times to fever resolution and microbiological eradication were similar in the two groups. Patients with the lock intervention received a shorter duration of systemic antibiotic therapy than that of the control patients (median, 11 days versus 16 days, respectively; P < 0.0001), and they were able to retain their CVCs for a median of 74 days after the onset of bacteremia. The M-EDTA-EtOH lock was associated with a significantly decreased rate of mechanical and infectious complications compared to that of the CVC removal/reinsertion group, who received a longer duration of systemic antimicrobial therapy. (This study has been registered at under registration no. NCT01539343.).  
  Address MD Anderson Cancer Center, Department of Infectious Diseases, Infection Control & Employee Health, Houston, Texas, USA  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0066-4804 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:27001822 Approved no  
  Call Number ref @ user @ Serial 100284  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: